The global sclerotherapy market is anticipated to grow at a higher CAGR in the forthcoming period. The primary objective of sclerotherapy is to trigger endothelial and vein wall injury in controlled environment. The resultant is elimination of abnormal vessels that transport retrograde flow without disturbing surrounding vessels that carry normal flow. In such cases, scelosant effect results in a fibrous cord that gets absorbed over time. Therefore, sclerotherapy is used in treatment of all types and dimensions of varicosities.
The therapy is considered as a standard treatment for reticular veins, leg telangiectasias and venulectasias. Sclerotherapy has been standardly used for major varicosities coupled with direct injection into saphenous vein at the saphenofemoral intersection. Therefore, on a commercial level, sclerotherapy is used extensively in treatment of valvular inadequacy of varicose veins.
Driving factors responsible for the growth of sclerotherapy market includes rising incidences of varicose veins and vein surgeries. Other factors such as rise in medical infrastructure, availability of large consumer pool in developed and emerging economies, sedentary lifestyle, rising prevalence of leg casualties stimulate the growth of the industry.
Segmentation based on type, the sclerotherapy market includes detergents, chemical irritants and osmotic agents. Segmentation based on application, the sclerotherapy industry includes hospitals & clinics. Geographically, sclerotherapy market spans North America, South America, Europe, Asia-Pacific, Middle-East and Africa. APAC and MEA market is anticipated to grow at a positive CAGR in the forthcoming period due to rising incidences of varicose veins. Also, growing need for sclerotherapy diagnosis is likely to contribute to these market. Europe and North America market is anticipated to grow at a higher CAGR in the forthcoming period owing to rising incidences of leg injuries, varicose veins and reticular veins.
The key players in the sclerotherapy industry include Kreussler, BTG, LGM Pharma, Changan Tianyu Group, Bioniche Pharma Group Ltd, Omega Pharmaceuticals, Angiodynamics, ENDO-FLEX and MTW ENDOSKOPIE.
This report studies the global Sclerotherapy market, analyzes and researches the Sclerotherapy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
• LGM Pharma
• Changan Tianyu group
• Bioniche Pharma Group Ltd
• Omega Pharmaceuticals
• MTW ENDOSKOPIE
• Cook Medical
Market segment by Regions/Countries, this report covers
• United States
• Southeast Asia
Market segment by Type, Sclerotherapy can be split into
• Osmotic Agents
• Chemical Irritants
Market segment by Application, Sclerotherapy can be split into
Research Support Specialist, USA